MarketInOut Stock Screener Log In | Sign Up

Champions Oncology Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Champions Oncology Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization66.95 mln
Float6.04 mln
Earnings Date12/15/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.48
Manipulation likely

Relative Strength

77 / 100
Strongly outperforming

Debt / Equity

2.82
Very high leverage

Pre-Tax Margin

-1%
Barely loss-making

ROE

-27.89
Deeply negative

Business Description

Champions Oncology is a US-based research company that helps pharmaceutical and biotechnology firms develop cancer drugs by implanting human tumors into specially bred mice, allowing scientists to study how those tumors respond to treatment. The company also offers Lumin Bioinformatics, a software tool that pulls together data from research and clinical studies to support drug development decisions. Founded in 1985 and based in Hackensack, New Jersey, Champions Oncology reaches its clients through online channels and a dedicated sales team.

Key Fundamentals

EPS-0.07
ROE-27.89
RPS4.38
ROIC-4.20
ROA-3.69
EBITDA, mln0.40
EV / EBITDA187
EV / EBIT-83.28
Revenue, mln60.66
EV / Revenue1.22

Quote Details

Last 4.81
Change 0 (0%)
Open 4.86
Volume 8,439
Turnover 40,592
Average Volume 8,727.57

Financial Ratios

Pre-Tax Profit Margin-1
Leverage Ratio8.55
Current Ratio1.03
Price / Book17.25
Price / Tangible Book18.58
Debt / Equity2.82
Price / Sales1.12

Financial Strength

Altman Z-Score-0.27
Piotroski F-Score 2 / 9
Beneish M-Score-1.48
Short Ratio5.90
Short % of Float1.14

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.91% 79 / 100   
1 Month -1.43% 50 / 100   
2 Months -20.63% 22 / 100   
6 Months -19.7% 27 / 100   
1 Year -29.26% 26 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog